Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 246

1.

Hypoxia-induced expression of VEGF splice variants and protein in four retinal cell types.

Watkins WM, McCollum GW, Savage SR, Capozzi ME, Penn JS, Morrison DG.

Exp Eye Res. 2013 Nov;116:240-6. doi: 10.1016/j.exer.2013.09.014. Epub 2013 Sep 26.

2.

Circumscribed outer foveolar defects in spinocerebellar ataxia type 7.

Watkins WM, Schoenberger SD, Lavin P, Agarwal A.

Retin Cases Brief Rep. 2013 Summer;7(3):294-6. doi: 10.1097/ICB.0b013e31828ef084.

PMID:
25391128
3.

Implementation of a reference standard and proficiency testing programme by the World Wide Antimalarial Resistance Network (WWARN).

Lourens C, Watkins WM, Barnes KI, Sibley CH, Guerin PJ, White NJ, Lindegardh N.

Malar J. 2010 Dec 25;9:375. doi: 10.1186/1475-2875-9-375.

4.

A "new" blood-group character related to the ABO system. 1952.

Bhende YM, Deshpande CK, Bhatia HM, Sanger R, Race RR, Morgan WT, Watkins WM.

Natl Med J India. 2008 Sep-Oct;21(5):264-6; discussion 266-7. No abstract available.

PMID:
19320334
5.

Characteristics of Plasmodium falciparum dhfr haplotypes that confer pyrimethamine resistance, Kilifi, Kenya, 1987--2006.

Certain LK, Briceño M, Kiara SM, Nzila AM, Watkins WM, Sibley CH.

J Infect Dis. 2008 Jun 15;197(12):1743-51. doi: 10.1086/588198.

6.

Antimalarial dosing regimens and drug resistance.

Barnes KI, Watkins WM, White NJ.

Trends Parasitol. 2008 Mar;24(3):127-34. doi: 10.1016/j.pt.2007.11.008. Epub 2008 Feb 11. Review.

PMID:
18262470
7.

A network to monitor antimalarial drug resistance: a plan for moving forward.

Sibley CH, Barnes KI, Watkins WM, Plowe CV.

Trends Parasitol. 2008 Jan;24(1):43-8. Epub 2007 Nov 26. Review.

PMID:
18042432
8.

Glycomic mapping of pseudomucinous human ovarian cyst glycoproteins: identification of Lewis and sialyl Lewis glycotopes.

Wu AM, Khoo KH, Yu SY, Yang Z, Kannagi R, Watkins WM.

Proteomics. 2007 Oct;7(20):3699-717.

PMID:
17880005
9.

World Antimalarial Resistance Network (WARN) IV: clinical pharmacology.

Barnes KI, Lindegardh N, Ogundahunsi O, Olliaro P, Plowe CV, Randrianarivelojosia M, Gbotosho GO, Watkins WM, Sibley CH, White NJ.

Malar J. 2007 Sep 6;6:122.

10.

Sulfadoxine-pyrimethamine pharmacokinetics in malaria: pediatric dosing implications.

Barnes KI, Little F, Smith PJ, Evans A, Watkins WM, White NJ.

Clin Pharmacol Ther. 2006 Dec;80(6):582-96.

PMID:
17178260
11.

The World Bank: false financial and statistical accounts and medical malpractice in malaria treatment.

Attaran A, Barnes KI, Bate R, Binka F, d'Alessandro U, Fanello CI, Garrett L, Mutabingwa TK, Roberts D, Sibley CH, Talisuna A, Van Geertruyden JP, Watkins WM.

Lancet. 2006 Jul 15;368(9531):247-52. No abstract available. Erratum in: Lancet. 2006 Jul 15;368(9531):202.

PMID:
16844495
12.

Tolerance is the key to understanding antimalarial drug resistance.

Hastings IM, Watkins WM.

Trends Parasitol. 2006 Feb;22(2):71-7. Epub 2006 Jan 10. Review.

PMID:
16406706
13.

Reduction of the efficacy of antifolate antimalarial therapy by folic acid supplementation.

Carter JY, Loolpapit MP, Lema OE, Tome JL, Nagelkerke NJ, Watkins WM.

Am J Trop Med Hyg. 2005 Jul;73(1):166-70.

PMID:
16014852
14.

Intensity of malaria transmission and the evolution of drug resistance.

Hastings IM, Watkins WM.

Acta Trop. 2005 Jun;94(3):218-29. Epub 2005 Apr 19. Review.

PMID:
15847846
15.

Antimalarial benzo[c]phenanthridines.

Nyangulu JM, Hargreaves SL, Sharples SL, Mackay SP, Waigh RD, Duval O, Mberu EK, Watkins WM.

Bioorg Med Chem Lett. 2005 Apr 15;15(8):2007-10.

PMID:
15808457
17.

Rare, highly pyrimethamine-resistant alleles of the Plasmodium falciparum dihydrofolate reductase gene from 5 African sites.

Bates SJ, Winstanley PA, Watkins WM, Alloueche A, Bwika J, Happi TC, Kremsner PG, Kublin JG, Premji Z, Sibley CH.

J Infect Dis. 2004 Nov 15;190(10):1783-92. Epub 2004 Oct 18.

PMID:
15499534
18.

The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses.

Watkins WM, Mberu EK, Winstanley PA, Plowe CV.

Parasitol Today. 1997 Dec;13(12):459-64.

PMID:
15275132
19.

WHO, the Global Fund, and medical malpractice in malaria treatment.

Attaran A, Barnes KI, Curtis C, d'Alessandro U, Fanello CI, Galinski MR, Kokwaro G, Looareesuwan S, Makanga M, Mutabingwa TK, Talisuna A, Trape JF, Watkins WM.

Lancet. 2004 Jan 17;363(9404):237-40. Review. No abstract available.

PMID:
14738799
20.

The genetic regulation of fucosylated and sialylated antigens on developing myeloid cells.

Watkins WM, Clarke JL.

Adv Exp Med Biol. 2001;491:231-65. Review.

PMID:
14533802
21.

Ralph Ambrose Kekwick, 11 November 1908 - 17 January 2000.

Creeth JM, Vallet L, Watkins WM.

Biogr Mem Fellows R Soc. 2002;48:235-49. No abstract available.

PMID:
13678071
22.

Pharmacokinetics and clinical effects of phenytoin and fosphenytoin in children with severe malaria and status epilepticus.

Ogutu BR, Newton CR, Muchohi SN, Otieno GO, Edwards G, Watkins WM, Kokwaro GO.

Br J Clin Pharmacol. 2003 Jul;56(1):112-9. Erratum in: Br J Clin Pharmacol. 2003 Oct;56(4):464.

23.

Plasmodium falciparum: in vitro activity of sulfadoxine and dapsone in field isolates from Kenya: point mutations in dihydropteroate synthase may not be the only determinants in sulfa resistance.

Mberu EK, Nzila AM, Nduati E, Ross A, Monks SM, Kokwaro GO, Watkins WM, Hopkins Sibley C.

Exp Parasitol. 2002 Jun-Jul;101(2-3):90-6.

PMID:
12427462
24.

Genetic diversity of Plasmodium falciparum parasites from Kenya is not affected by antifolate drug selection.

Nzila AM, Mberu EK, Nduati E, Ross A, Watkins WM, Sibley CH.

Int J Parasitol. 2002 Nov;32(12):1469-76.

PMID:
12392912
25.

Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial.

Sulo J, Chimpeni P, Hatcher J, Kublin JG, Plowe CV, Molyneux ME, Marsh K, Taylor TE, Watkins WM, Winstanley PA.

Lancet. 2002 Oct 12;360(9340):1136-43.

PMID:
12387962
26.

Monitoring of drug-resistant malaria in Africa.

Mutabingwa TK, Watkins WM, d'Alessandro U.

Lancet. 2002 Sep 14;360(9336):875. No abstract available.

PMID:
12243945
27.

Pharmacokinetics of phenytoin following intravenous and intramuscular administration of fosphenytoin and phenytoin sodium in the rabbit.

Muchohi SN, Kokwaro GO, Maitho TE, Munenge RW, Watkins WM, Edwards G.

Eur J Drug Metab Pharmacokinet. 2002 Apr-Jun;27(2):83-9.

PMID:
12064376
28.

The evolution of drug-resistant malaria: the role of drug elimination half-life.

Hastings IM, Watkins WM, White NJ.

Philos Trans R Soc Lond B Biol Sci. 2002 Apr 29;357(1420):505-19. Review.

29.

Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next?

Sibley CH, Hyde JE, Sims PF, Plowe CV, Kublin JG, Mberu EK, Cowman AF, Winstanley PA, Watkins WM, Nzila AM.

Trends Parasitol. 2001 Dec;17(12):582-8. Review.

PMID:
11756042
30.

Arthur Ernest Mourant: 11 April 1904-29 August 1994.

Misson GP, Bishop AC, Watkins WM.

Biogr Mem Fellows R Soc. 1999;45:331-48. No abstract available.

PMID:
11624283
31.

A tribute to Walter J.T. Morgan.

Watkins WM.

Transfus Med. 2001 Aug;11(4):239-351. No abstract available.

PMID:
11548710
32.

The ABO blood group system: historical background.

Watkins WM.

Transfus Med. 2001 Aug;11(4):243-65. No abstract available.

PMID:
11532183
33.

Unravelling the biochemical basis of blood group ABO and Lewis antigenic specificity.

Morgan WT, Watkins WM.

Glycoconj J. 2000 Jul-Sep;17(7-9):501-30.

PMID:
11421345
34.

The changing in vitro susceptibility pattern to pyrimethamine/sulfadoxine in Plasmodium falciparum field isolates from Kilifi, Kenya.

Mberu EK, Mosobo MK, Nzila AM, Kokwaro GO, Sibley CH, Watkins WM.

Am J Trop Med Hyg. 2000 Mar;62(3):396-401.

PMID:
11037785
35.

Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate Pyrimethamine/Sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum.

Nzila AM, Nduati E, Mberu EK, Hopkins Sibley C, Monks SA, Winstanley PA, Watkins WM.

J Infect Dis. 2000 Jun;181(6):2023-8. Epub 2000 Jun 5. Erratum in: J Infect Dis 2000 Sep;182(3):1011.

PMID:
10837185
36.

Prevalence of anaemia in patients attending an outpatient clinic in western Rift Valley in Kenya during a low malaria season.

Carter JY, Lema OE, Mukunza HK, Varia HN, Munyere AS, Watkins WM, Watkins KM.

East Afr Med J. 1999 May;76(5):251-4.

PMID:
10750503
37.
38.

Studies on anti-folate antimalarials in east Africa.

Ortelli F, Maxwell CA, Curtis J, Watkins WM.

Parassitologia. 1999 Sep;41(1-3):313-4. Review.

PMID:
10697874
39.

Walter Thomas James Morgan: a biographical sketch.

Watkins WM.

Biochim Biophys Acta. 1999 Oct 8;1455(2-3):63-7. No abstract available.

40.
41.

Changing home treatment of childhood fevers by training shop keepers in rural Kenya.

Marsh VM, Mutemi WM, Muturi J, Haaland A, Watkins WM, Otieno G, Marsh K.

Trop Med Int Health. 1999 May;4(5):383-9.

42.

Averting a malaria disaster.

White NJ, Nosten F, Looareesuwan S, Watkins WM, Marsh K, Snow RW, Kokwaro G, Ouma J, Hien TT, Molyneux ME, Taylor TE, Newbold CI, Ruebush TK 2nd, Danis M, Greenwood BM, Anderson RM, Olliaro P.

Lancet. 1999 Jun 5;353(9168):1965-7. No abstract available.

PMID:
10371589
43.

More on 'the efficacy of antifolate antimalarial combinations in Africa'.

Watkins WM, Mberu EK, Winstanley PA, Plowe CV.

Parasitol Today. 1999 Apr;15(4):131-2. No abstract available.

PMID:
10322331
45.

Quinine sensitivity of isolates of Plasmodium falciparum from the coast of Kenya.

Haruki K, Winstanley PA, Watkins WM, Marsh K.

Trans R Soc Trop Med Hyg. 1998 Mar-Apr;92(2):195-6. No abstract available.

PMID:
9764332
46.

Antiprotozoal properties of 16,17-dihydrobrachycalyxolide from Vernonia brachycalyx.

Oketch-Rabah HA, Brøgger Christensen S, Frydenvang K, Dossaji SF, Theander TG, Cornett C, Watkins WM, Kharazmi A, Lemmich E.

Planta Med. 1998 Aug;64(6):559-62.

PMID:
9741304
47.
48.
49.

Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance.

Plowe CV, Cortese JF, Djimde A, Nwanyanwu OC, Watkins WM, Winstanley PA, Estrada-Franco JG, Mollinedo RE, Avila JC, Cespedes JL, Carter D, Doumbo OK.

J Infect Dis. 1997 Dec;176(6):1590-6.

PMID:
9395372
50.

Malarone-donation programme in Africa.

Bloland PB, Kazembe PN, Watkins WM, Doumbo OK, Nwanyanwu OC, Ruebush TK 2nd.

Lancet. 1997 Nov 29;350(9091):1624-5.

PMID:
9393355

Supplemental Content

Loading ...
Support Center